Ozempic’s popularity leads to shortages for people with Type 2 diabetes
(By Sydney Lupkin for NPR) Jim Cox had heard of people with Type 2 diabetes who were unable to get
Read More
GLP-1s drugs
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans
(By Tammie Smith for The Kaiser Family Foundation published June 12, 2024) Affordable Care Act (ACA) Marketplace plans rarely cover
Read MoreWeight loss drug coverage gets more complicated
(By Jakob Emerson for Becker’s Hospital Review) In less than a month’s time, a federal lawmaker warned weight loss drugs
Read MoreMedicare spending on weight loss drugs may be lower than previously thought: Report
(By Rylee Wilson for Becker’s Hospital Review) Medicare spending on GLP-1 medications may not be as high as some estimates predict
Read MorePoll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease
(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they
Read MoreGross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss
(By Chris Lee for The Kaiser Family Foundation published March 23, 2024) A KFF analysis shows that gross total Medicare
Read More